Clinical trial
Evaluation of a Treatment Algorithm for the Management of TAVI Patients With Significant Concomitant Mitral or Tricuspid Regurgitation
NCT07623083 is registered in ClinicalTrials.gov with Josep Rodes-Cabau as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of a Treatment Algorithm for the Management of TAVI Patients With Significant Concomitant Mitral or Tricuspid Regurgitation
- Lead sponsor
- Josep Rodes-Cabau
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- June 5, 2026
- Completion date
- June 5, 2034
- Enrollment
- 300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis, mitral regurgitation, transcatheter aortic valve implantation (tavi), tricuspid regurgitation